TAKEDA PHARMACEUTICAL CO Ltd. (NASDAQOTH:TKPHF)

CAPS Rating: No stars

Results 1 - 2 of 2

Recs

0
Member Avatar stratton6 (96.85) Submitted: 3/21/2010 12:35:18 PM : Outperform Start Price: $41.45 TKPHF Score: -71.30

Largest Japanese pharmaceutical company (227 years old). Recent globalization efforts in the past three years have resulted in several US sites.

Recs

1
Member Avatar mrevrgreen (87.89) Submitted: 8/4/2007 4:18:52 PM : Outperform Start Price: $65.35 TKPHF Score: -68.29

Takeda has a good pharmaceutical pipeline. It makes Actos a TZD for treatment of diabetes. It's major competitor (avandia by GSK) to the TZD market just had quite an unfoavorable study. The current recommendation is not to start anyone new on their competitors drug (Avandia).

I expect at least a 10% bump in new prescriptions.

Results 1 - 2 of 2

Featured Broker Partners


Advertisement